Aura Biosciences Ownership | Who Owns Aura Biosciences?
Aura Biosciences Ownership Summary
Aura Biosciences is owned by 141.67% institutional investors, 1.18% insiders. Tcg crossover management is the largest institutional shareholder, holding 14.13% of AURA shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 8.16% of its assets in Aura Biosciences shares.
AURA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Aura Biosciences | 141.67% | 1.18% | -42.86% |
| Sector | Healthcare Stocks | 245.07% | 12.10% | -157.17% |
| Industry | Biotech Stocks | 380.48% | 11.73% | -292.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Tcg crossover management | 9.53M | 14.13% | $67.69M |
| Matrix capital management company, lp | 6.92M | 11.47% | $46.31M |
| Suvretta capital management | 7.21M | 10.68% | $51.16M |
| Frazier life sciences management | 7.10M | 10.53% | $50.41M |
| Long focus capital management | 5.12M | 7.59% | $36.35M |
| Blackrock funding, inc. /de | 4.71M | 6.98% | $33.42M |
| Adage capital partners gp | 4.64M | 6.88% | $32.94M |
| Caligan partners lp | 4.30M | 6.37% | $30.52M |
| Vanguard capital management | 4.10M | 6.08% | $29.11M |
| Blackrock | 3.01M | 6.08% | $22.72M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Matrix capital management company, lp | 6.92M | 100.00% | $46.31M |
| Medicxi ventures management (jersey) | 3.04M | 12.16% | $21.58M |
| Fcpm iii services b.v. | 4.05M | 3.84% | $28.78M |
| B group | 764.24K | 2.55% | $5.43M |
| Acorn capital advisors | 929.08K | 1.80% | $6.60M |
| Tcg crossover management | 9.53M | 1.63% | $67.69M |
| Regency capital management inc.\de | 540.39K | 1.53% | $3.84M |
| Foresite capital management vi | 1.33M | 1.47% | $9.47M |
| Caligan partners lp | 4.30M | 1.44% | $30.52M |
| Frazier life sciences management | 7.10M | 1.10% | $50.41M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tcg crossover management | 9.53M | 1.63% | 9.53M |
| Caligan partners lp | 4.30M | 1.44% | 4.07M |
| Fcpm iii services b.v. | 4.05M | 3.84% | 4.05M |
| Orbimed advisors | 3.33M | 0.44% | 3.33M |
| Suvretta capital management | 7.21M | 0.94% | 2.83M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Eventide asset management | - | - | -4.08M |
| Millennium management | 617.47K | 0.00% | -480.16K |
| Samsara biocapital | 584.85K | 0.47% | -415.15K |
| Ensign peak advisors | - | - | -390.69K |
| Decheng capital | - | - | -360.48K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Tcg crossover management | 9.53M | 1.63% | 9.53M | $67.69M |
| Fcpm iii services b.v. | 4.05M | 3.84% | 4.05M | $28.78M |
| Orbimed advisors | 3.33M | 0.44% | 3.33M | $23.67M |
| Ra capital management | 2.50M | 0.15% | 2.50M | $17.75M |
| Redmile group | 1.67M | 0.79% | 1.67M | $11.83M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -4.00 |
| Advisory services network | -6.00 |
| Root financial partners | -7.00 |
| Mai capital management | -16.00 |
| Capital performance advisors llp | -25.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 149 | 17.32% | 95,555,899 | 87.80% | 141 | 1.99% | 96 | 52.38% | 28 | -30.00% |
| Mar 31, 2026 | 53 | -54.31% | 8,140,896 | -83.79% | 13 | 0.23% | 29 | -44.23% | 15 | -60.53% |
| Dec 31, 2025 | 76 | -28.30% | 32,618,162 | -36.85% | 49 | 0.62% | 32 | -40.74% | 28 | 27.27% |
| Sep 30, 2025 | 103 | 7.29% | 51,053,713 | 1.75% | 87 | 1.18% | 53 | -1.85% | 21 | -25.00% |
| Jun 30, 2025 | 101 | 8.60% | 50,603,535 | 53.66% | 87 | 2.02% | 57 | 32.56% | 29 | -3.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Eventide Healthcare & Life Sciences I | 4.08M | 8.16% | -1.72M |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.96M | 3.06% | 57.13K |
| Vanguard Morn Total Stk Mkt Idx Investor | 2.90M | 2.81% | 141.60K |
| Vanguard Total Stock Mkt Idx Inv | 2.90M | 2.81% | 141.60K |
| Franklin Biotechnology Discv A(acc)USD | 1.31M | 1.35% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.13M | 1.18% | 26.73K |
| iShares Russell 2000 ETF | 1.15M | 1.11% | -20.35K |
| Franklin Biotechnology Discovery A | 765.62K | 0.79% | - |
| Fidelity Extended Market Index | 497.13K | 0.48% | -5.27K |
| iShares Biotechnology ETF | 469.81K | 0.45% | -1.43K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Gibney Anthony S | See Remarks | Sell | $82.33K |
| May 07, 2026 | Matrix Capital Management Company, LP | - | Sell | $39.04M |
| Apr 16, 2026 | Kilroy Conor | See Remarks | Sell | $82.40K |
| Feb 17, 2026 | Kilroy Conor | See Remarks | Sell | $61.00K |
| Feb 17, 2026 | Plavsic Mark | Chief Technology Officer | Sell | $80.24K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | - |
| 2026 Q2 | - | 3 |
| 2026 Q1 | - | 7 |
| 2025 Q4 | - | 4 |
| 2025 Q3 | - | 1 |
AURA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools